Experts consensus statement on Xiyanping Injection in clinical practice(children).
10.19540/j.cnki.cjcmm.20190521.502
- Author:
Zhi-Fei WANG
1
;
Ping RONG
2
;
Rong MA
2
;
Yan-Ming XIE
1
;
Ying DING
3
;
Xue-Feng WANG
4
;
Si-Yan ZHAN
5
;
Xiu-Hui LI
6
Author Information
1. Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
2. First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin 300381,China.
3. the First Affiliated Hospital of Henan University of Traditional Chinese Medicine Zhengzhou 450004,China.
4. Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang 110032,China.
5. School of Public Health,Peking University Beijing 100191,China.
6. Beijing You'an Hospital Affiliated to Capital Medical University Beijing 100069,China.
- Publication Type:Journal Article
- Keywords:
Xiyanping Injection;
classification of evidence;
clinical application;
expert consensus;
recommendation
- MeSH:
Child;
China;
Consensus;
Drugs, Chinese Herbal;
therapeutic use;
Humans;
Injections;
Medicine, Chinese Traditional;
Nonprescription Drugs;
Pediatrics
- From:
China Journal of Chinese Materia Medica
2019;44(14):2932-2936
- CountryChina
- Language:Chinese
-
Abstract:
Xiyanping Injection is a commonly used medicine in clinical treatment,which is recommended by many pediatric disease guidelines/consensus. However,the instraction is relatively simple and lack of guidance for clinical application,which affects the efficacy and brings safety risks. Therefore,more detailed clinical guidance is urgently needed. This consensus is formulated by clinical experts of traditional Chinese medicine and Western medicine in pediatrics. This consensus follows Manual for the clinical experts consensus of Chinese patent medicine which published by China Association of Chinese Medicine. The study identified clinical problems using clinical investigation,searched the literature based on PICO clinical problems,using GRADE system to carry out evidences evaluation,classification and recommendation,and adopted the nominal grouping method to reach expert consensus. The consensus combines evidence-based evidence with expert experience,sufficient evidence of clinical problems would lead to " recommendations",and clinical problems with insufficient evidence will lead to " consensus suggestions". This expert consensus recommends the indications,intervention time for treatment,route of drug administration,dose conversion,the indications of being used alone,suitability and taboos of medicine combination,and introduces the safety and clinical application,to provide reference for clinical using.
